Educational guide
KPV and LL-37 Interaction: Synergistic | Peptide Database
Compound Profiles KPV Anti-Inflammatory Tripeptide | Alpha-MSH Fragment Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Compound Profiles
KPV
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like steroids.
LL-37
Human Cathelicidin | Antimicrobial Peptide
Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..
Combined Organ Load
Frequently Asked Questions
Can I take KPV with LL-37?
Yes, KPV and LL-37 can generally be taken together. Complementary antimicrobial and healing effects.
Is KPV and LL-37 safe together?
Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between KPV and LL-37?
Complementary antimicrobial and healing effects. This assessment has 95% confidence and is based on documented research data.
How should I time KPV and LL-37?
KPV has a half-life of 1-2 hours and LL-37 has a half-life of Short (rapid proteolytic degradation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.